Financhill
Buy
74

MCK Quote, Financials, Valuation and Earnings

Last price:
$719.51
Seasonality move :
4.32%
Day range:
$710.51 - $724.26
52-week range:
$464.42 - $731.00
Dividend yield:
0.38%
P/E ratio:
27.86x
P/S ratio:
0.26x
P/B ratio:
--
Volume:
1.3M
Avg. volume:
1M
1-year change:
28.26%
Market cap:
$89.9B
Revenue:
$359.1B
EPS (TTM):
$25.83

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MCK
McKesson
$94.2B $9.83 20.2% 18.43% $748.84
BUDZ
Weed
-- -- -- -- --
CAH
Cardinal Health
$55.3B $2.15 1.61% 104.13% $156.74
COR
Cencora
$75.8B $4.10 8.14% 56.12% $317.23
HSIC
Henry Schein
$3.2B $1.11 2.79% 49.48% $76.39
PNPL
Pineapple
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MCK
McKesson
$719.51 $748.84 $89.9B 27.86x $0.71 0.38% 0.26x
BUDZ
Weed
$0.03 -- $4.2M 180.00x $0.00 0% --
CAH
Cardinal Health
$154.44 $156.74 $36.9B 24.09x $0.51 1.31% 0.17x
COR
Cencora
$291.24 $317.23 $56.4B 33.79x $0.55 0.74% 0.19x
HSIC
Henry Schein
$69.99 $76.39 $8.5B 21.87x $0.00 0% 0.70x
PNPL
Pineapple
$0.1000 -- $7.3M -- $0.00 0% 49.15x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MCK
McKesson
157.93% 0.870 6.69% 0.51x
BUDZ
Weed
-- -1.086 -- --
CAH
Cardinal Health
162.31% 0.200 22.64% 0.44x
COR
Cencora
88.58% 0.081 14.53% 0.48x
HSIC
Henry Schein
46.62% 1.386 29.56% 0.58x
PNPL
Pineapple
-- 2.419 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MCK
McKesson
$3.6B $1.7B 79.77% -- 1.72% $7.5B
BUDZ
Weed
-- -$434.7K -- -- -- -$71.8K
CAH
Cardinal Health
$2.1B $656M 46.27% -- 1.35% $2.8B
COR
Cencora
$3.1B $1.2B 24.2% 183.42% 1.41% $3.2B
HSIC
Henry Schein
$1B $200M 5.42% 8.28% 5.68% -$6M
PNPL
Pineapple
-- -- -- -- -- --

McKesson vs. Competitors

  • Which has Higher Returns MCK or BUDZ?

    Weed has a net margin of 1.39% compared to McKesson's net margin of --. McKesson's return on equity of -- beat Weed's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MCK
    McKesson
    4.01% $10.01 $4B
    BUDZ
    Weed
    -- -$0.00 --
  • What do Analysts Say About MCK or BUDZ?

    McKesson has a consensus price target of $748.84, signalling upside risk potential of 4.08%. On the other hand Weed has an analysts' consensus of -- which suggests that it could fall by --. Given that McKesson has higher upside potential than Weed, analysts believe McKesson is more attractive than Weed.

    Company Buy Ratings Hold Ratings Sell Ratings
    MCK
    McKesson
    10 3 0
    BUDZ
    Weed
    0 0 0
  • Is MCK or BUDZ More Risky?

    McKesson has a beta of 0.525, which suggesting that the stock is 47.469% less volatile than S&P 500. In comparison Weed has a beta of 0.835, suggesting its less volatile than the S&P 500 by 16.517%.

  • Which is a Better Dividend Stock MCK or BUDZ?

    McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.38%. Weed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.47% of its earnings as a dividend. Weed pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MCK or BUDZ?

    McKesson quarterly revenues are $90.8B, which are larger than Weed quarterly revenues of --. McKesson's net income of $1.3B is higher than Weed's net income of -$440.5K. Notably, McKesson's price-to-earnings ratio is 27.86x while Weed's PE ratio is 180.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus -- for Weed. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MCK
    McKesson
    0.26x 27.86x $90.8B $1.3B
    BUDZ
    Weed
    -- 180.00x -- -$440.5K
  • Which has Higher Returns MCK or CAH?

    Cardinal Health has a net margin of 1.39% compared to McKesson's net margin of 0.92%. McKesson's return on equity of -- beat Cardinal Health's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MCK
    McKesson
    4.01% $10.01 $4B
    CAH
    Cardinal Health
    3.87% $2.10 $5.8B
  • What do Analysts Say About MCK or CAH?

    McKesson has a consensus price target of $748.84, signalling upside risk potential of 4.08%. On the other hand Cardinal Health has an analysts' consensus of $156.74 which suggests that it could grow by 1.49%. Given that McKesson has higher upside potential than Cardinal Health, analysts believe McKesson is more attractive than Cardinal Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    MCK
    McKesson
    10 3 0
    CAH
    Cardinal Health
    9 5 0
  • Is MCK or CAH More Risky?

    McKesson has a beta of 0.525, which suggesting that the stock is 47.469% less volatile than S&P 500. In comparison Cardinal Health has a beta of 0.662, suggesting its less volatile than the S&P 500 by 33.768%.

  • Which is a Better Dividend Stock MCK or CAH?

    McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.38%. Cardinal Health offers a yield of 1.31% to investors and pays a quarterly dividend of $0.51 per share. McKesson pays 10.47% of its earnings as a dividend. Cardinal Health pays out 58.57% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MCK or CAH?

    McKesson quarterly revenues are $90.8B, which are larger than Cardinal Health quarterly revenues of $54.9B. McKesson's net income of $1.3B is higher than Cardinal Health's net income of $506M. Notably, McKesson's price-to-earnings ratio is 27.86x while Cardinal Health's PE ratio is 24.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus 0.17x for Cardinal Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MCK
    McKesson
    0.26x 27.86x $90.8B $1.3B
    CAH
    Cardinal Health
    0.17x 24.09x $54.9B $506M
  • Which has Higher Returns MCK or COR?

    Cencora has a net margin of 1.39% compared to McKesson's net margin of 0.95%. McKesson's return on equity of -- beat Cencora's return on equity of 183.42%.

    Company Gross Margin Earnings Per Share Invested Capital
    MCK
    McKesson
    4.01% $10.01 $4B
    COR
    Cencora
    4.06% $3.68 $9B
  • What do Analysts Say About MCK or COR?

    McKesson has a consensus price target of $748.84, signalling upside risk potential of 4.08%. On the other hand Cencora has an analysts' consensus of $317.23 which suggests that it could grow by 8.92%. Given that Cencora has higher upside potential than McKesson, analysts believe Cencora is more attractive than McKesson.

    Company Buy Ratings Hold Ratings Sell Ratings
    MCK
    McKesson
    10 3 0
    COR
    Cencora
    9 6 0
  • Is MCK or COR More Risky?

    McKesson has a beta of 0.525, which suggesting that the stock is 47.469% less volatile than S&P 500. In comparison Cencora has a beta of 0.604, suggesting its less volatile than the S&P 500 by 39.596%.

  • Which is a Better Dividend Stock MCK or COR?

    McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.38%. Cencora offers a yield of 0.74% to investors and pays a quarterly dividend of $0.55 per share. McKesson pays 10.47% of its earnings as a dividend. Cencora pays out 27.58% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MCK or COR?

    McKesson quarterly revenues are $90.8B, which are larger than Cencora quarterly revenues of $75.5B. McKesson's net income of $1.3B is higher than Cencora's net income of $717.9M. Notably, McKesson's price-to-earnings ratio is 27.86x while Cencora's PE ratio is 33.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus 0.19x for Cencora. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MCK
    McKesson
    0.26x 27.86x $90.8B $1.3B
    COR
    Cencora
    0.19x 33.79x $75.5B $717.9M
  • Which has Higher Returns MCK or HSIC?

    Henry Schein has a net margin of 1.39% compared to McKesson's net margin of 3.47%. McKesson's return on equity of -- beat Henry Schein's return on equity of 8.28%.

    Company Gross Margin Earnings Per Share Invested Capital
    MCK
    McKesson
    4.01% $10.01 $4B
    HSIC
    Henry Schein
    31.57% $0.88 $7.6B
  • What do Analysts Say About MCK or HSIC?

    McKesson has a consensus price target of $748.84, signalling upside risk potential of 4.08%. On the other hand Henry Schein has an analysts' consensus of $76.39 which suggests that it could grow by 9.14%. Given that Henry Schein has higher upside potential than McKesson, analysts believe Henry Schein is more attractive than McKesson.

    Company Buy Ratings Hold Ratings Sell Ratings
    MCK
    McKesson
    10 3 0
    HSIC
    Henry Schein
    3 9 1
  • Is MCK or HSIC More Risky?

    McKesson has a beta of 0.525, which suggesting that the stock is 47.469% less volatile than S&P 500. In comparison Henry Schein has a beta of 0.871, suggesting its less volatile than the S&P 500 by 12.861%.

  • Which is a Better Dividend Stock MCK or HSIC?

    McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.38%. Henry Schein offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.47% of its earnings as a dividend. Henry Schein pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MCK or HSIC?

    McKesson quarterly revenues are $90.8B, which are larger than Henry Schein quarterly revenues of $3.2B. McKesson's net income of $1.3B is higher than Henry Schein's net income of $110M. Notably, McKesson's price-to-earnings ratio is 27.86x while Henry Schein's PE ratio is 21.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus 0.70x for Henry Schein. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MCK
    McKesson
    0.26x 27.86x $90.8B $1.3B
    HSIC
    Henry Schein
    0.70x 21.87x $3.2B $110M
  • Which has Higher Returns MCK or PNPL?

    Pineapple has a net margin of 1.39% compared to McKesson's net margin of --. McKesson's return on equity of -- beat Pineapple's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    MCK
    McKesson
    4.01% $10.01 $4B
    PNPL
    Pineapple
    -- -- --
  • What do Analysts Say About MCK or PNPL?

    McKesson has a consensus price target of $748.84, signalling upside risk potential of 4.08%. On the other hand Pineapple has an analysts' consensus of -- which suggests that it could fall by --. Given that McKesson has higher upside potential than Pineapple, analysts believe McKesson is more attractive than Pineapple.

    Company Buy Ratings Hold Ratings Sell Ratings
    MCK
    McKesson
    10 3 0
    PNPL
    Pineapple
    0 0 0
  • Is MCK or PNPL More Risky?

    McKesson has a beta of 0.525, which suggesting that the stock is 47.469% less volatile than S&P 500. In comparison Pineapple has a beta of 36.643, suggesting its more volatile than the S&P 500 by 3564.318%.

  • Which is a Better Dividend Stock MCK or PNPL?

    McKesson has a quarterly dividend of $0.71 per share corresponding to a yield of 0.38%. Pineapple offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. McKesson pays 10.47% of its earnings as a dividend. Pineapple pays out -- of its earnings as a dividend. McKesson's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MCK or PNPL?

    McKesson quarterly revenues are $90.8B, which are larger than Pineapple quarterly revenues of --. McKesson's net income of $1.3B is higher than Pineapple's net income of --. Notably, McKesson's price-to-earnings ratio is 27.86x while Pineapple's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for McKesson is 0.26x versus 49.15x for Pineapple. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MCK
    McKesson
    0.26x 27.86x $90.8B $1.3B
    PNPL
    Pineapple
    49.15x -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock